You are currently browsing the Osteoarthritis Blog blog archives for the day Thursday, June 24th, 2010.

Support and Brace Support and Brace

Calendar

June 2010
M T W T F S S
« May   Jul »
 123456
78910111213
14151617181920
21222324252627
282930  

Archive for June 24th, 2010

cancel study

Pfizer suspended clinical trial of their new infusion therapy drug, Tanezumab. ¬†Apparently some patient’s condition became worse.

The worldwide program was cancelled after the FDA reported the osteoarthritis in some patients became so bad so quickly that they needed to have their knees replaced!

Pfizer is no longer accepting new patients into their trials of Tanezumab and has suspended dosing of existing patients in the OA program.

The FDA is demanding that Pfizer present information on the problems associated with Tanezumab reported in their other clinical studies.